Literature DB >> 21988043

From gut microflora imbalance to mycobacteria infection: is there a relationship with chronic intestinal inflammatory diseases?

Giovanni Tomasello1, Maurizio Bellavia, Vincenzo Davide Palumbo, Maria Concetta Gioviale, Provvidenza Damiani, Attilio Ignazio Lo Monte.   

Abstract

The gut of a healthy adult harbours a myriad of different microbial species. It is estimated that approximately 10 14 are present in total bacterial colony forming units (CFU). Each colony colonizes a specific intestinal tract. In healthy adult, the main control of intestinal bacterial colonization occurs through gastric acidity but also other factors can influence the intestinal microenvironment such as pH, temperature, competition among different bacterial strains, peristalsis, drugs, radiotherapy and much more. Impaired microbial homeostasis leads to an alteration of the permeability of tissue, together with the activation of the intestinal immune system MALT (mucosal associated lymphoid tissue). In this regard we discuss the increasing experimental evidences of the role of commensal microbiota in the activation of specific intestinal immunocompetent cells. The aforementioned micro-environmental changes provide the substrate for the etiopathogenetic outbreak of numerous pathologies of gastro-intestinal tract, such as intestinal chronic inflammation (Crohn's disease and Ulcerative Colitis), together with a miscellany of extra intestinal disorders. This article is an overview of the latest scientific findings about the close causal relationship between intestinal microbial flora and inflammatory bowel diseases or other extra-intestinal diseases; it is also mentioned the possible relationship between mycobacteria and Chron's disease. Finally we analyse the beneficial role of probiotics.

Entities:  

Mesh:

Year:  2011        PMID: 21988043

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  6 in total

Review 1.  Gut microbiota imbalance and chaperoning system malfunction are central to ulcerative colitis pathogenesis and can be counteracted with specifically designed probiotics: a working hypothesis.

Authors:  Maurizio Bellavia; Giovanni Tomasello; Marcello Romeo; Provvidenza Damiani; Attilio I Lo Monte; Luciano Lozio; Claudia Campanella; Antonella Marino Gammazza; Francesca Rappa; Giovanni Zummo; Massimo Cocchi; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Med Microbiol Immunol       Date:  2013-07-18       Impact factor: 3.402

2.  A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation.

Authors:  Valerio Mezzasalma; Enrico Manfrini; Emanuele Ferri; Anna Sandionigi; Barbara La Ferla; Irene Schiano; Angela Michelotti; Vincenzo Nobile; Massimo Labra; Patrizia Di Gennaro
Journal:  Biomed Res Int       Date:  2016-08-09       Impact factor: 3.411

3.  Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease.

Authors:  Sutapa Sarkar; Diana Kimono; Muayad Albadrani; Ratanesh K Seth; Philip Busbee; Hasan Alghetaa; Dwayne E Porter; Geoff I Scott; Bryan Brooks; Mitzi Nagarkatti; Prakash Nagarkatti; Saurabh Chatterjee
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

4.  Effects of Torreya grandis Kernel Oil on Lipid Metabolism and Intestinal Flora in C57BL/6J Mice.

Authors:  Minghui Xiao; Minjie Huang; Weiwei Huan; Jie Dong; Jianbo Xiao; Jiasheng Wu; Deqian Wang; Lili Song
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

Review 5.  Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.

Authors:  Matteo Serino; Vincent Blasco-Baque; Simon Nicolas; Remy Burcelin
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

6.  Transfer of dysbiotic gut microbiota has beneficial effects on host liver metabolism.

Authors:  Simon Nicolas; Vincent Blasco-Baque; Audren Fournel; Jerome Gilleron; Pascale Klopp; Aurelie Waget; Franck Ceppo; Alysson Marlin; Roshan Padmanabhan; Jason S Iacovoni; François Tercé; Patrice D Cani; Jean-François Tanti; Remy Burcelin; Claude Knauf; Mireille Cormont; Matteo Serino
Journal:  Mol Syst Biol       Date:  2017-03-16       Impact factor: 11.429

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.